Alaunos Therapeutics, Inc. (TCRT)
NASDAQ: TCRT · Real-Time Price · USD
3.308
-0.042 (-1.25%)
Mar 4, 2026, 12:14 PM EST - Market open

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
Biotechnology
10.00K5.00K2.92M398.00K
146.00K
Biotechnology Growth
100.00%-99.83%634.17%-
-97.71%
Total
10.00K5.00K2.92M398.00K
146.00K
Total Growth
100.00%-99.83%634.17%-
-97.71%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
United States
10.00K5.00K2.92M398.00K
146.00K
United States Growth
100.00%-99.83%634.17%-
-97.71%
Total
10.00K5.00K2.92M398.00K
146.00K
Total Growth
100.00%-99.83%634.17%-
-97.71%
Source: S&P Global Market Intelligence.